Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAirtel Africa Regulatory News (AAF)

Share Price Information for Airtel Africa (AAF)

Share Price is delayed by 15 minutes
Get Live Data
358.00    -10.80 (-2.93%)
Bid:
357.00
Ask:
357.40
Spread: 0.40 (0.112%)
Market Cap: £13.04b
AAF Live PriceLast checked at - London Stock Exchange

Intraday Airtel Africa Share Chart

Directorate Change

9 May 2024 16:00

RNS Number : 8540N
Airtel Africa PLC
09 May 2024
 

 

Airtel Africa plc

("Airtel Africa", or "Company")

 

Directorate Change

 

London and Lagos, 9 May 2024: Airtel Africa plc, a leading provider of telecommunications and mobile money services, with a presence in 14 countries across Africa, is pleased to announce that Paul Arkwright, CMG, is to be appointed as an Independent non-executive director of the Company, with immediate effect.

Paul is a former British Ambassador with 34 years' experience in the UK Diplomatic Service. His career included postings as the UK Ambassador to the Netherlands (2009-13), UK High Commissioner to Nigeria (2015-18), CEO of the UK-Africa Investment Summit (2019), Acting UK Ambassador to DRC (2020), and Regional Ambassador for Africa, COP26 Summit. He is a skilled negotiator at the highest levels with excellent international networking and communication skills and is a fluent French speaker.

Following his retirement from the UK Diplomatic Service in 2020, Paul founded an independent consultancy advising international business on investing and operating across Africa. Between January 2021 to date, Paul acted as a Special Advisor to the Chair and Board of Airtel Africa focusing on political, legal and regulatory issues pursuant to the terms of a consultancy agreement.

Paul is on the Advisory Panel of Africa Matters Limited, a part of JS Held, and is a member of the Central Council of the Royal Over-Seas League. In 2016, he was awarded a CMG by her Majesty Queen Elizabeth II for services to international diplomacy.

 

 

-ENDS-

 

Enquiries

 

Airtel Africa - Investor Relations

Alastair Jones

Investor.relations@africa.airtel.com

 

+44 7446 858 280

+44 7464 830 011

+44 207 493 9315

 

 

Hudson Sandler

Nick Lyon

Emily Dillon

airtelafrica@hudsonsandler.com

+44 207 796 4133

 

 

 

 

 

 

About Airtel Africa

Airtel Africa is a leading provider of telecommunications and mobile money services, with a presence in 14 countries in Africa, primarily in East Africa and Central and West Africa.

Airtel Africa offers an integrated suite of telecommunications solutions to its subscribers, including mobile voice and data services as well as mobile money services both nationally and internationally.

The Group aims to continue providing a simple and intuitive customer experience through streamlined customer journeys.

www.airtel.africa

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAXKLFBZELZBBE
Date   Source Headline
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20263:30 pmRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares and Share Buyback Update
30th Jan 20267:00 amRNS3rd Quarter Results
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20268:00 amRNSNotice of Results
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20263:30 pmRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20254:30 pmRNSCommencement of audit tender process
1st Dec 20253:30 pmRNSTotal Voting Rights
11th Nov 20253:00 pmRNSDirectorate change
3rd Nov 20254:00 pmRNSDirector/PDMR Shareholding
3rd Nov 20253:00 pmRNSInterim Dividend Currency Exchange Rates
3rd Nov 20252:00 pmRNSTotal Voting Rights
28th Oct 20257:00 amRNSHalf-year Report
28th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.